The management of thrombosis in stroke requires that several questions
be answered concerning the diagnosis, aetiology, identification of pr
oblems, general and specific aspects of care, and prevention of furthe
r vascular events. Stroke is a clinical diagnosis, but cranial compute
d tomography (CT) scanning is required where there is diagnostic uncer
tainty or cerebral haemorrhage must be excluded. No specific medical t
herapies are of proven benefit in acute stroke but several large trial
s are currently evaluating promising antithrombotic therapies (antipla
telet, anticoagulant and thrombolytic agents). Aspirin has a proven ro
le in the prevention of further vascular events after a stroke or tran
sient ischaemic attack (TIA). In stroke and TIA patients with non-rheu
matic atrial fibrillation, warfarin is highly effective at preventing
recurrent events. The risk of recurrent stroke in patients with a symp
tomatic, severe carotid artery stenosis is greatly reduced by endarter
ectomy.